Trial Profile
A randomized, double-blind, placebo controlled trial to evaluate the efficacy of Fluviral influenza vaccine [SPD 707] in healthy adults 18 to 49 years of age
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 16 Jan 2017
Price :
$35
*
At a glance
- Drugs GSK 1536489A (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- Sponsors ID Biomedical Corporation
- 12 Dec 2006 Status change
- 09 Dec 2005 New trial record.